Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Targeting Immune Checkpoints in Lung Cancer: Current Landscape and Future Prospects.

Long L, Zhao C, Ozarina M, Zhao X, Yang J, Chen H.

Clin Drug Investig. 2019 Apr;39(4):341-353. doi: 10.1007/s40261-018-00746-5. Review.

PMID:
30778885
2.

High expression of synthesis of cytochrome c oxidase 2 and TP53-induced glycolysis and apoptosis regulator can predict poor prognosis in human lung adenocarcinoma.

Liu J, Lu F, Gong Y, Zhao C, Pan Q, Ballantyne S, Zhao X, Tian S, Chen H.

Hum Pathol. 2018 Jul;77:54-62. doi: 10.1016/j.humpath.2017.12.029. Epub 2018 Apr 7.

PMID:
29634976
3.

Genotypic and phenotypic signatures to predict immune checkpoint blockade therapy response in patients with colorectal cancer.

Zhao X, May A, Lou E, Subramanian S.

Transl Res. 2018 Jun;196:62-70. doi: 10.1016/j.trsl.2018.02.001. Epub 2018 Feb 12. Review.

4.

Clinical Significance of Gli-1 And Caveolin-1 Expression in the Human Small Cell Lung Cancer

Wu J, Di D, Zhao C, Pan Q, Liu Y, Zhang X, Zhao X, Chen H.

Asian Pac J Cancer Prev. 2018 Feb 26;19(2):401-406.

5.

Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.

Dauer P, Zhao X, Gupta VK, Sharma N, Kesh K, Gnamlin P, Dudeja V, Vickers SM, Banerjee S, Saluja A.

Cancer Res. 2018 Mar 1;78(5):1321-1333. doi: 10.1158/0008-5472.CAN-17-2320. Epub 2017 Dec 19.

6.

Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy.

Wu J, Di D, Zhao C, Liu Y, Chen H, Gong Y, Zhao X, Chen H.

Curr Cancer Drug Targets. 2018;18(6):558-566. doi: 10.2174/1568009618666171129223533. Review.

PMID:
29189160
7.

A transwell assay that excludes exosomes for assessment of tunneling nanotube-mediated intercellular communication.

Thayanithy V, O'Hare P, Wong P, Zhao X, Steer CJ, Subramanian S, Lou E.

Cell Commun Signal. 2017 Nov 13;15(1):46. doi: 10.1186/s12964-017-0201-2.

8.

High expression of monocarboxylate transporter 4 predicts poor prognosis in patients with lung adenocarcinoma.

Ruan Y, Zeng F, Cheng Z, Zhao X, Fu P, Chen H.

Oncol Lett. 2017 Nov;14(5):5727-5734. doi: 10.3892/ol.2017.6964. Epub 2017 Sep 15.

9.

Tumor location impacts immune response in mouse models of colon cancer.

Zhao X, Li L, Starr TK, Subramanian S.

Oncotarget. 2017 Jun 9;8(33):54775-54787. doi: 10.18632/oncotarget.18423. eCollection 2017 Aug 15.

10.

Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy.

Zhao X, Subramanian S.

Pharmacol Ther. 2018 Jan;181:76-84. doi: 10.1016/j.pharmthera.2017.07.004. Epub 2017 Jul 15. Review.

PMID:
28720430
11.

The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma.

Fu P, Chen F, Pan Q, Zhao X, Zhao C, Cho WC, Chen H.

Onco Targets Ther. 2017 Feb 14;10:819-835. doi: 10.2147/OTT.S123912. eCollection 2017. Review.

12.

Overexpression of junctional adhesion molecule-A and EphB2 predicts poor survival in lung adenocarcinoma patients.

Zhao C, Wang A, Lu F, Chen H, Fu P, Zhao X, Chen H.

Tumour Biol. 2017 Feb;39(2):1010428317691000. doi: 10.1177/1010428317691000.

PMID:
28231727
13.

Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy.

Zhao X, Subramanian S.

Cancer Res. 2017 Feb 15;77(4):817-822. doi: 10.1158/0008-5472.CAN-16-2379. Epub 2017 Feb 3. Review.

14.

Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.

Zhao X, Fan W, Xu Z, Chen H, He Y, Yang G, Yang G, Hu H, Tang S, Wang P, Zhang Z, Xu P, Yu M.

Oncotarget. 2016 Dec 6;7(49):81110-81122. doi: 10.18632/oncotarget.13212.

15.

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.

Vogel RI, Pulver T, Heilmann W, Mooneyham A, Mullany S, Zhao X, Shahi M, Richter J, Klein M, Chen L, Ding R, Konecny G, Kommoss S, Winterhoff B, Ghebre R, Bazzaro M.

Oncotarget. 2016 May 24;7(21):30962-76. doi: 10.18632/oncotarget.8821.

16.

Clinical significance of circulating miRNA detection in lung cancer.

Zhao C, Lu F, Chen H, Zhao F, Zhu Z, Zhao X, Chen H.

Med Oncol. 2016 May;33(5):41. doi: 10.1007/s12032-016-0757-5. Epub 2016 Mar 31. Review.

PMID:
27034265
17.

Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.

Banerjee S, Modi S, McGinn O, Zhao X, Dudeja V, Ramakrishnan S, Saluja AK.

Clin Cancer Res. 2016 Jan 15;22(2):415-25. doi: 10.1158/1078-0432.CCR-15-1155. Epub 2015 Sep 24.

18.

Autophagy knocked down by high-risk HPV infection and uterine cervical carcinogenesis.

Li X, Gong Z, Zhang L, Zhao C, Zhao X, Gu X, Chen H.

Int J Clin Exp Med. 2015 Jul 15;8(7):10304-14. eCollection 2015. Review.

19.

Dysregulation of JAM-A plays an important role in human tumor progression.

Zhao C, Lu F, Chen H, Zhao X, Sun J, Chen H.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):7242-8. eCollection 2014. Review.

20.

The prognostic value of autophagy-related markers beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis.

He Y, Zhao X, Subahan NR, Fan L, Gao J, Chen H.

Tumour Biol. 2014 Aug;35(8):7317-26. doi: 10.1007/s13277-014-2060-4. Epub 2014 May 17. Review.

PMID:
24838948

Supplemental Content

Loading ...
Support Center